Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19 […]

The European health regulator started reviewing data on AstraZeneca and Oxford University’s potential Covid-19 vaccine in real time, the first of such moves aimed at speeding up any approval process in the region for a vaccine.

Fujifilm Holdings Corp. said a late-stage study of Avigan showed the antiviral drug reduced recovery times for Covid-19 patients with non-severe symptoms, boosting expectations for regulatory approval in Japan.

Eli Lilly and Co. said the company’s rheumatoid arthritis drug baricitinib shortened the recovery time for hospitalized Covid-19 patients also given Gilead Sciences Inc.’s antiviral remdesivir.

U.S. hospitals have turned down about a third of their allocated supplies of the Covid-19 drug remdesivir since July as need for the costly antiviral wanes, the Department of Health and Human Services (HHS) confirmed.

Johnson & Johnson’s Janssen Pharmaceutical made a strategic call to halt development of pimodivir, an antiviral treatment for influenza A.

The U.S. Food and Drug Administration expanded the emergency use authorization of Gilead Inc.’s experimental antiviral Covid-19 treatment remdesivir to allow the product’s use in all hospitalized Covid-19 patients.

Gilead remdesivir study finds only marginal benefit for moderate COVID-19 patients (Reuters) – Moderately ill COVID-19 patients saw their condition improve after a 5-day course of Gilead Sciences Inc’s (GILD.O) […]

Veru Inc. is developing a dual anti-inflammatory/antiviral medication to combat severe Covid-19 infections.

Gilead Sciences Inc. filed a marketing application with the U.S. Food and Drug Administration for the company’s experimental Covid-19 drug remdesivir.